Cognex (NASDAQ:CGNX) Price Target Cut to $42.00 by Analysts at Truist Financial

Cognex (NASDAQ:CGNX) had its target price cut by Truist Financial from $45.00 to $42.00 in a research report sent to investors on Thursday, Marketbeat.com reports. They currently have a hold rating on the scientific and technical instruments company’s stock.

Other equities research analysts also recently issued reports about the company. Barclays reiterated an “overweight” rating and set a $56.00 target price (up from $55.00) on shares of Cognex in a report on Friday, October 31st. UBS Group reaffirmed a “buy” rating and issued a $58.00 price target on shares of Cognex in a report on Friday, October 31st. Robert W. Baird set a $45.00 target price on shares of Cognex in a research note on Friday, October 31st. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $35.00 price objective (down previously from $45.00) on shares of Cognex in a report on Wednesday, December 3rd. Finally, DA Davidson set a $38.00 price target on shares of Cognex and gave the stock a “neutral” rating in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Cognex has an average rating of “Moderate Buy” and a consensus target price of $45.79.

Cognex Stock Up 1.1%

NASDAQ:CGNX opened at $36.17 on Thursday. The company has a market cap of $6.06 billion, a P/E ratio of 56.52 and a beta of 1.53. The firm’s 50 day moving average is $40.26 and its two-hundred day moving average is $39.19. Cognex has a fifty-two week low of $22.67 and a fifty-two week high of $49.76.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.06. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The company had revenue of $264.00 million during the quarter, compared to analysts’ expectations of $261.86 million. During the same period in the previous year, the company earned $0.20 EPS. The business’s quarterly revenue was up 18.0% compared to the same quarter last year. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Research analysts forecast that Cognex will post 0.61 earnings per share for the current fiscal year.

Cognex Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Thursday, November 13th were given a dividend of $0.085 per share. The ex-dividend date of this dividend was Thursday, November 13th. This is a positive change from Cognex’s previous quarterly dividend of $0.08. This represents a $0.34 annualized dividend and a yield of 0.9%. Cognex’s dividend payout ratio (DPR) is currently 53.13%.

Insider Transactions at Cognex

In related news, Director Robert Willett sold 6,704 shares of the firm’s stock in a transaction on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by insiders.

Institutional Trading of Cognex

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Cognex by 2.1% in the third quarter. Vanguard Group Inc. now owns 18,598,728 shares of the scientific and technical instruments company’s stock worth $842,522,000 after purchasing an additional 374,999 shares during the period. Nordea Investment Management AB grew its holdings in shares of Cognex by 13.4% during the third quarter. Nordea Investment Management AB now owns 8,025,371 shares of the scientific and technical instruments company’s stock worth $361,382,000 after purchasing an additional 949,599 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its stake in shares of Cognex by 32.0% during the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company’s stock valued at $181,436,000 after purchasing an additional 1,474,832 shares during the last quarter. Disciplined Growth Investors Inc. MN increased its stake in shares of Cognex by 0.9% in the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company’s stock valued at $151,264,000 after buying an additional 40,927 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in Cognex by 43.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,024,355 shares of the scientific and technical instruments company’s stock valued at $137,003,000 after purchasing an additional 922,149 shares during the period. 88.12% of the stock is owned by institutional investors.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.